ROCCHETTI MARCELLA

Arici, M., Hsu, S., Ferrandi, M., Barassi, P., Ronchi, C., Torre, E., et al. (2024). Selective SERCA2a activator as a candidate for chronic heart failure therapy. JOURNAL OF TRANSLATIONAL MEDICINE, 22(1) [10.1186/s12967-024-04874-9]. Detail

Zarbo, C., Stolarski, M., Zamparini, M., Damiani, S., Casiraghi, L., Rocchetti, M., et al. (2023). Time perspective affects daily time use and daily functioning in individuals with Schizophrenia Spectrum Disorders: Results from the multicentric DiAPAson study. JOURNAL OF PSYCHIATRIC RESEARCH, 160(April 2023), 93-100 [10.1016/j.jpsychires.2023.02.012]. Detail

Altomare, C., Bartolucci, C., Sala, L., Balbi, C., Burrello, J., Pietrogiovanna, N., et al. (2023). A dynamic clamping approach using in silico IK1 current for discrimination of chamber-specific hiPSC-derived cardiomyocytes. COMMUNICATIONS BIOLOGY, 6(1) [10.1038/s42003-023-04674-9]. Detail

Arici, M., Ferrandi, M., Barassi, P., Hsu, S., Torre, E., Luraghi, A., et al. (2023). Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function. THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 384(1), 231-244 [10.1124/jpet.122.001335]. Detail

Torre, E., Arici, M., Lodrini, A., Ferrandi, M., Barassi, P., Hsu, S., et al. (2022). SERCA2a stimulation by istaroxime improves intracellular Ca2+ handling and diastolic dysfunction in a model of diabetic cardiomyopathy. CARDIOVASCULAR RESEARCH, 118(4), 1020-1032 [10.1093/cvr/cvab123]. Detail